Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
01 1Biophore India Pharmaceuticals Pvt Ltd
02 1Abboxia Ab
03 2Alkem Laboratories
04 1Altan Pharma
05 1Annora Pharma
06 1Aristo Pharma GmbH
07 1Avet Pharmaceuticals
08 2Azurity Pharma
09 1BB FARMA Srl
10 1BENEDETTI SpA
11 8Bayer AG
12 1Bionpharma
13 1Brooks laboratories Limited
14 5Central Procurement & Supplies Unit
15 1Cherubino Limited
16 1DOC Generici
17 1EG SpA
18 2Ebb Medical
19 2Future Health Pharma Gmbh
20 1GERMED PLIVA PHARMA SpA
21 1Ha Noi CPC1 Pharmaceutical JSC
22 2Italfarmaco S.p.A
23 1LABORATOIRE X.0
24 2Laboratoire X.O
25 2Laboratoire X.O.
26 2MEDOCHEMIE LTD
27 1Madras Pharmaceuticals
28 1Medartuum
29 1Neuraxpharm
30 6ORIFARM GROUP AS
31 1Omnia L?kemedel Ab
32 1PROGRAMMI SANIT.INTEGRATI Srl
33 2Reyoung pharmaceutical
34 1SINTACTICA Srl
35 2STADA Arzneimittel
36 1Sandoz B2B
37 1Sofgen Pharma
38 1Sun Pharmaceutical Industries Limited
39 1THEPHARMANETWORK LLC
40 4Xo Laboratory
41 1Yangtze River Pharmaceutical Group
42 1Blank
01 6CAPSULE;ORAL
02 1Coated Tablet
03 1Concentrate For Solution For Infusion
04 14Film Coated Tablet
05 1Film-Coated Tablet
06 1INJ
07 10Infusion Solution
08 2Injection
09 1Nimodipine 10Mg 50Ml 1 Units Parenteral Use
10 1Oral Solution
11 1Perfusion Solution
12 2Powder for Injection
13 5SOLUTION;ORAL
14 2Softgelatin Capsule
15 6Solution For Infusion
16 1Solution For Perfusion
17 1TAB
18 1TABLET
19 1Tablet
20 13Blank
01 2Allowed
02 5Approved
03 5Authorised
04 4Authorized
05 1Cancelled
06 4DISCN
07 6Deregistered
08 1Invalid
09 2Marketed
10 2Not Marketed
11 2Originator
12 3Prescription
13 6RX
14 2Suspended
15 1Withdrawn
16 25Blank
01 2Brainal
02 1Iskidrop
03 8NIMODIPINE
04 2NIMOTOP
05 2NYMALIZE
06 2Nemotan®
07 1Nimobrain
08 4Nimodipine
09 1Nimodipine Altan
10 1Nimodipine Labesfal
11 1Nimodipine Remontal
12 1Nimodipino Stada
13 1Nimodipino Stadafarma
14 30Nimotop
15 1Nimotop 02 Mg/Ml
16 1Nimotop Iv 50Ml
17 1Nimotop Tabs 30Mg 100S
18 1Nimovaso sol
19 2Periplum
20 1Sobrepina
21 7Blank
01 1Canada
02 3China
03 2Estonia
04 4India
05 14Italy
06 7Malta
07 2Moldova
08 4Norway
09 2South Africa
10 7Spain
11 11Sweden
12 2Switzerland
13 11USA
14 1Vietnam
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 6MG/ML
Packaging :
Approval Date : 2025-01-22
Application Number : 213409
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 60MG/10ML
Packaging :
Approval Date :
Application Number : 213409
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 3MG/ML
Packaging :
Approval Date : 2024-07-09
Application Number : 216937
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2007-05-02
Application Number : 77811
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NYMALIZE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2013-05-10
Application Number : 203340
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NYMALIZE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 6MG/ML
Packaging :
Approval Date : 2020-04-08
Application Number : 203340
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NIMOTOP
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-12-28
Application Number : 18869
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Nimotop
Dosage Form :
Dosage Strength : 36 Bust Grat 30 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Nimotop
Dosage Form :
Dosage Strength : 36 Cpr Riv 30 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2008-01-17
Application Number : 76740
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Nimodipine
Dosage Form :
Dosage Strength : Gtt Os 25 Ml 30 Mg/0.75 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Periplum
Dosage Form :
Dosage Strength : 36 Cpr Riv 30 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2015-07-24
Application Number : 201832
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2007-04-17
Application Number : 77067
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NIMODIPINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2014-04-07
Application Number : 90103
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Nimotop
Dosage Form :
Dosage Strength : 36 Cpr Riv 30 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Nimotop
Dosage Form :
Dosage Strength : 36 Cpr Riv 30 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Nimodipine
Dosage Form :
Dosage Strength : Gtt Os 25 Ml 30 Mg/0.75 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Nimodipine
Dosage Form :
Dosage Strength : Gtt Os 25 Ml 30 Mg/0.75 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
